Terms: = Lung cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306 AND Prognosis
10 results:
1. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.
Itahashi K; Irie T; Yuda J; Kumagai S; Tanegashima T; Lin YT; Watanabe S; Goto Y; Suzuki J; Aokage K; Tsuboi M; Minami Y; Ishii G; Ohe Y; Ise W; Kurosaki T; Suzuki Y; Koyama S; Nishikawa H
Sci Immunol; 2022 Oct; 7(76):eabk0957. PubMed ID: 36206353
[TBL] [Abstract] [Full Text] [Related]
2. Circ_0020123 regulates autophagy, glycolysis, and malignancy by upregulating irf4 through eliminating miR-193a-3p-mediated suppression of irf4 in non-small cell lung cancer.
Yang XP; Zheng YZ; Tan J; Tian RJ; Shen P; Cai WJ; Liao HY
Neoplasma; 2022 Mar; 69(2):392-403. PubMed ID: 35225648
[TBL] [Abstract] [Full Text] [Related]
3. Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from lung Adenocarcinoma and Clinical Prognostic Analysis.
Feng X; Guan N; Xu E; Miao Y; Li C
Dis Markers; 2021; 2021():8585633. PubMed ID: 35003395
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Value of EZH2 in Non-Small-Cell lung cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract] [Full Text] [Related]
5. irf4 instructs effector Treg differentiation and immune suppression in human cancer.
Alvisi G; Brummelman J; Puccio S; Mazza EM; Tomada EP; Losurdo A; Zanon V; Peano C; Colombo FS; Scarpa A; Alloisio M; Vasanthakumar A; Roychoudhuri R; Kallikourdis M; Pagani M; Lopci E; Novellis P; Blume J; Kallies A; Veronesi G; Lugli E
J Clin Invest; 2020 Jun; 130(6):3137-3150. PubMed ID: 32125291
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancer.
Kim NY; Pyo JS
Pathol Res Pract; 2017 Jul; 213(7):778-782. PubMed ID: 28554757
[TBL] [Abstract] [Full Text] [Related]
7. CPEB4 and irf4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancer.
Wu YY; Hwang YT; Perng WC; Chian CF; Ho CL; Lee SC; Chang H; Terng HJ; Chao TY
J Formos Med Assoc; 2017 Feb; 116(2):114-122. PubMed ID: 27113098
[TBL] [Abstract] [Full Text] [Related]
8. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
Gao Q; Yang S; Kang MQ
Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
[TBL] [Abstract] [Full Text] [Related]
9. Total en bloc spondylectomy for lung cancer metastasis to the spine.
Murakami H; Kawahara N; Demura S; Kato S; Yoshioka K; Tomita K
J Neurosurg Spine; 2010 Oct; 13(4):414-7. PubMed ID: 20887137
[TBL] [Abstract] [Full Text] [Related]
10. [Results of radiotherapy of bronchial carcinoma (author's transl)].
Heilmann HP; Doppelfeld E; Fernholz HJ; Birkner R; Schlicker H; Becker G; Gordon-Harris L; Hackl A; Sager WD; Jentsch F; Kraft W; Bünemann H; Horstmann W; Hassenstein E; Kuttig H; Wieland C; Schmidt N; Müller A; Quäck J; Buchelt L; Hess F; Koop EA; von Lieven H; Heinze HG; Castrup W; Wannenmacher M; Rey G; Voss AC; Nüse A; Eibach E; Grund W; Bohndorf W; Schindler G
Dtsch Med Wochenschr; 1976 Oct; 101(43):1557-62. PubMed ID: 62648
[TBL] [Abstract] [Full Text] [Related]
